Literature DB >> 10556395

Fetal presentation of congenital long QT syndrome.

M T Donofrio1, S D Gullquist, N G O'Connell, F O Redwine.   

Abstract

Thirty-two-week prenatal ultrasound revealed a fetal heart rate of 100 bpm with decreased variability on the heart rate tracing. Echocardiogram documented normal anatomy and sinus bradycardia. Newborn electrocardiogram revealed sinus rhythm at 100 bpm with a QTc of 0.657. Follow-up electrocardiogram revealed a QTc interval of 0.568, 2:1 atrioventricular block with a ventricular rate of 60 bpm, and ventricular ectopy. The infant received a pacemaker and beta-blocker therapy. Long QT syndrome should be in the differential diagnosis of the fetus with bradycardia and decreased heart rate variability in the absence of distress. Early diagnosis allowed for preventative care in the infant and identification of family members at risk.

Entities:  

Mesh:

Year:  1999        PMID: 10556395     DOI: 10.1007/s002469900510

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  4 in total

1.  Antenatal presentation of congenital long QT syndrome: A prenatal diagnosis not to be missed.

Authors:  Alban-Elouen Baruteau; Jean-Marc Schleich
Journal:  Pediatr Cardiol       Date:  2008-07-26       Impact factor: 1.655

Review 2.  Arrhythmia pharmacogenomics: methodological considerations.

Authors:  Dan M Roden; Prince J Kannankeri; Dawood Darbar
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

3.  Survival of a Newborn with 2:1 Atrioventricular Block, Long QT Syndrome, and Torsades de Pointes.

Authors:  Shubho Sarkar; Michael Brumund; Rani Darling; Christopher S Snyder
Journal:  Ochsner J       Date:  2007

Review 4.  Fetal long QT syndrome manifested as atrioventricular block and ventricular tachycardia: a case report and a review of the literature.

Authors:  Sanitra Anuwutnavin; Prapat Wanitpongpan; Paweena Chungsomprasong; Jarupim Soongswang; Nattinee Srisantiroj; Tuangsit Wataganara
Journal:  Pediatr Cardiol       Date:  2012-09-18       Impact factor: 1.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.